Integrated Bioinformatics Analysis of Shared Genes, miRNA, Biological Pathways and Their Potential Role as Therapeutic Targets in Huntington’s Disease Stages

Huntington’s Disease (HD) is a progressive neurodegenerative disease caused by CAG repeat expansion in the huntingtin gene (HTT). The HTT gene was the first disease-associated gene mapped to a chromosome, but the pathophysiological mechanisms, genes, proteins or miRNAs involved in HD remain poorly u...

Full description

Bibliographic Details
Main Authors: Christiana C. Christodoulou, Eleni Zamba Papanicolaou
Format: Article
Language:English
Published: MDPI AG 2023-03-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/24/5/4873
_version_ 1797615090289082368
author Christiana C. Christodoulou
Eleni Zamba Papanicolaou
author_facet Christiana C. Christodoulou
Eleni Zamba Papanicolaou
author_sort Christiana C. Christodoulou
collection DOAJ
description Huntington’s Disease (HD) is a progressive neurodegenerative disease caused by CAG repeat expansion in the huntingtin gene (HTT). The HTT gene was the first disease-associated gene mapped to a chromosome, but the pathophysiological mechanisms, genes, proteins or miRNAs involved in HD remain poorly understood. Systems bioinformatics approaches can divulge the synergistic relationships of multiple omics data and their integration, and thus provide a holistic approach to understanding diseases. The purpose of this study was to identify the differentially expressed genes (DEGs), HD-related gene targets, pathways and miRNAs in HD and, more specifically, between the pre-symptomatic and symptomatic HD stages. Three publicly available HD datasets were analysed to obtain DEGs for each HD stage from each dataset. In addition, three databases were used to obtain HD-related gene targets. The shared gene targets between the three public databases were compared, and clustering analysis was performed on the common shared genes. Enrichment analysis was performed on (i) DEGs identified for each HD stage in each dataset, (ii) gene targets from the public databases and (iii) the clustering analysis results. Furthermore, the hub genes shared between the public databases and the HD DEGs were identified, and topological network parameters were applied. Identification of HD-related miRNAs and their gene targets was obtained, and a miRNA-gene network was constructed. Enriched pathways identified for the 128 common genes revealed pathways linked to multiple neurodegeneration diseases (HD, Parkinson’s disease, Spinocerebellar ataxia), MAPK and HIF-1 signalling pathways. Eighteen HD-related hub genes were identified based on network topological analysis of MCC, degree and closeness. The highest-ranked genes were <i>FoxO3</i> and <i>CASP3</i>, <i>CASP3</i> and <i>MAP2</i> were found for betweenness and eccentricity and <i>CREBBP</i> and <i>PPARGC1A</i> were identified for the clustering coefficient. The miRNA-gene network identified eleven miRNAs (mir-19a-3p, mir-34b-3p, mir-128-5p, mir-196a-5p, mir-34a-5p, mir-338-3p, mir-23a-3p and mir-214-3p) and eight genes (<i>ITPR1</i>, <i>CASP3</i>, <i>GRIN2A</i>, <i>FoxO3</i>, <i>TGM2</i>, <i>CREBBP, MTHFR</i> and <i>PPARGC1A</i>). Our work revealed that various biological pathways seem to be involved in HD either during the pre-symptomatic or symptomatic stages of HD. This may offer some clues for the molecular mechanisms, pathways and cellular components underlying HD and how these may act as potential therapeutic targets for HD.
first_indexed 2024-03-11T07:21:34Z
format Article
id doaj.art-71edab9861c241ab9590e288e5e5b268
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-11T07:21:34Z
publishDate 2023-03-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-71edab9861c241ab9590e288e5e5b2682023-11-17T07:54:37ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672023-03-01245487310.3390/ijms24054873Integrated Bioinformatics Analysis of Shared Genes, miRNA, Biological Pathways and Their Potential Role as Therapeutic Targets in Huntington’s Disease StagesChristiana C. Christodoulou0Eleni Zamba Papanicolaou1Neuroepidemiology Department, The Cyprus Institute of Neurology and Genetics, 2371 Nicosia, CyprusNeuroepidemiology Department, The Cyprus Institute of Neurology and Genetics, 2371 Nicosia, CyprusHuntington’s Disease (HD) is a progressive neurodegenerative disease caused by CAG repeat expansion in the huntingtin gene (HTT). The HTT gene was the first disease-associated gene mapped to a chromosome, but the pathophysiological mechanisms, genes, proteins or miRNAs involved in HD remain poorly understood. Systems bioinformatics approaches can divulge the synergistic relationships of multiple omics data and their integration, and thus provide a holistic approach to understanding diseases. The purpose of this study was to identify the differentially expressed genes (DEGs), HD-related gene targets, pathways and miRNAs in HD and, more specifically, between the pre-symptomatic and symptomatic HD stages. Three publicly available HD datasets were analysed to obtain DEGs for each HD stage from each dataset. In addition, three databases were used to obtain HD-related gene targets. The shared gene targets between the three public databases were compared, and clustering analysis was performed on the common shared genes. Enrichment analysis was performed on (i) DEGs identified for each HD stage in each dataset, (ii) gene targets from the public databases and (iii) the clustering analysis results. Furthermore, the hub genes shared between the public databases and the HD DEGs were identified, and topological network parameters were applied. Identification of HD-related miRNAs and their gene targets was obtained, and a miRNA-gene network was constructed. Enriched pathways identified for the 128 common genes revealed pathways linked to multiple neurodegeneration diseases (HD, Parkinson’s disease, Spinocerebellar ataxia), MAPK and HIF-1 signalling pathways. Eighteen HD-related hub genes were identified based on network topological analysis of MCC, degree and closeness. The highest-ranked genes were <i>FoxO3</i> and <i>CASP3</i>, <i>CASP3</i> and <i>MAP2</i> were found for betweenness and eccentricity and <i>CREBBP</i> and <i>PPARGC1A</i> were identified for the clustering coefficient. The miRNA-gene network identified eleven miRNAs (mir-19a-3p, mir-34b-3p, mir-128-5p, mir-196a-5p, mir-34a-5p, mir-338-3p, mir-23a-3p and mir-214-3p) and eight genes (<i>ITPR1</i>, <i>CASP3</i>, <i>GRIN2A</i>, <i>FoxO3</i>, <i>TGM2</i>, <i>CREBBP, MTHFR</i> and <i>PPARGC1A</i>). Our work revealed that various biological pathways seem to be involved in HD either during the pre-symptomatic or symptomatic stages of HD. This may offer some clues for the molecular mechanisms, pathways and cellular components underlying HD and how these may act as potential therapeutic targets for HD.https://www.mdpi.com/1422-0067/24/5/4873Huntington’s Diseasemolecular mechanismsbioinformatics approachesmonogenic diseaseneurodegenerative disease
spellingShingle Christiana C. Christodoulou
Eleni Zamba Papanicolaou
Integrated Bioinformatics Analysis of Shared Genes, miRNA, Biological Pathways and Their Potential Role as Therapeutic Targets in Huntington’s Disease Stages
International Journal of Molecular Sciences
Huntington’s Disease
molecular mechanisms
bioinformatics approaches
monogenic disease
neurodegenerative disease
title Integrated Bioinformatics Analysis of Shared Genes, miRNA, Biological Pathways and Their Potential Role as Therapeutic Targets in Huntington’s Disease Stages
title_full Integrated Bioinformatics Analysis of Shared Genes, miRNA, Biological Pathways and Their Potential Role as Therapeutic Targets in Huntington’s Disease Stages
title_fullStr Integrated Bioinformatics Analysis of Shared Genes, miRNA, Biological Pathways and Their Potential Role as Therapeutic Targets in Huntington’s Disease Stages
title_full_unstemmed Integrated Bioinformatics Analysis of Shared Genes, miRNA, Biological Pathways and Their Potential Role as Therapeutic Targets in Huntington’s Disease Stages
title_short Integrated Bioinformatics Analysis of Shared Genes, miRNA, Biological Pathways and Their Potential Role as Therapeutic Targets in Huntington’s Disease Stages
title_sort integrated bioinformatics analysis of shared genes mirna biological pathways and their potential role as therapeutic targets in huntington s disease stages
topic Huntington’s Disease
molecular mechanisms
bioinformatics approaches
monogenic disease
neurodegenerative disease
url https://www.mdpi.com/1422-0067/24/5/4873
work_keys_str_mv AT christianacchristodoulou integratedbioinformaticsanalysisofsharedgenesmirnabiologicalpathwaysandtheirpotentialroleastherapeutictargetsinhuntingtonsdiseasestages
AT elenizambapapanicolaou integratedbioinformaticsanalysisofsharedgenesmirnabiologicalpathwaysandtheirpotentialroleastherapeutictargetsinhuntingtonsdiseasestages